-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FgAUyTrh5HedtKjiIZWHYc9xP0cFJCqGVtgxjVrshF+wRsXBIroDhtAMTLh6APcN lFMp+c3tFrHWJfZpLQYnXg== 0001103581-03-000005.txt : 20030501 0001103581-03-000005.hdr.sgml : 20030501 20030501105745 ACCESSION NUMBER: 0001103581-03-000005 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030430 ITEM INFORMATION: Changes in registrant's certifying accountant FILED AS OF DATE: 20030501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MOLECULAR DIAGNOSTICS INC CENTRAL INDEX KEY: 0000075439 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364296006 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-00935 FILM NUMBER: 03675347 BUSINESS ADDRESS: STREET 1: 900 NORTH FRANKLIN STREET STREET 2: SUITE 210 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 4078490290 MAIL ADDRESS: STREET 1: 900 NORTH FRANKLIN STREET 1 STREET 2: SUITE 210 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: BELL NATIONAL CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC COAST HOLDINGS INC DATE OF NAME CHANGE: 19830303 FORMER COMPANY: FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP DATE OF NAME CHANGE: 19990527 8-K 1 mcdg8k050103.txt FORM 8-K - MOLECULAR DIAGNOSTICS, INC. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 30, 2003 MOLECULAR DIAGNOSTICS, INC. (Exact Name of Company as Specified in Its Charter) Delaware 0-935 36-4296006 (State or other Jurisdiction (Commission File Number) (IRS Employer Of Incorporation) Identification Number) 414 NORTH ORLEANS STREET SUITE 510 CHICAGO, ILLINOIS 60610 (Address and Zip Code of Principal Executive Offices) (312) 222-9550 (Registrant's telephone number, including area code) ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT. The Board of Directors and the Audit Committee, after reviewing proposals from several firms, engaged Altschuler Melvoin & Glasser LLP as Molecular Diagnostics, Inc.'s ("MDI") independent auditors for the fiscal year ended December 31, 2002. The engagement is effective April 30, 2003. During the two most recent fiscal years and through April 30, 2003, MDI has not consulted with Altschuler Melvoin & Glasser, LLP regarding either the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the MDI's financial statements. Altschuler Melvoin & Glasser LLP has not provided MDI with a written report or oral advice regarding such principles or audit opinion. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MOLECULAR DIAGNOSTICS, INC. /s/ Peter P. Gombrich ------------------------------- Peter P Gombrich Chairman and Chief Executive Officer, Acting Chief Financial Officer Date: May 1, 2003 -----END PRIVACY-ENHANCED MESSAGE-----